Sustained NPY overexpression in the PVN results in obesity via temporarily increasing food intake

Obesity (Silver Spring). 2009 Jul;17(7):1448-50. doi: 10.1038/oby.2008.670. Epub 2009 Feb 19.

Abstract

Increasing neuropeptide Y (NPY) signaling in the paraventricular nucleus (PVN) by recombinant adeno-associated virus (rAAV)-mediated overexpression of NPY in rats, results in hyperphagia and obesity in rats. To determine the importance of hyperphagia in the observed obesity phenotype, we pair-fed a group of AAV-NPY-injected rats to AAV-control-injected rats and compared parameters of energy balance to ad libitum fed AAV-NPY-injected rats. For 3 weeks, AAV-NPY-injected rats, received the same amount of food as ad libitum-fed rats injected with control rAAV They did not gain more body weight than these controls. When allowed access to food ad libitum, these AAV-NPY-injected rats increased food intake, which subsequently decreased when rats reached the same body weight as AAV-NPY-injected rats that were fed ad libitum for the entire study. These data indicate that overexpression of NPY in the PVN results in obesity by increasing food intake until a certain body weight is achieved.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenoviridae
  • Animals
  • Body Temperature / physiology
  • Body Weight / physiology
  • Disease Models, Animal
  • Eating / drug effects
  • Eating / physiology
  • Hyperphagia / complications*
  • Hyperphagia / metabolism*
  • Hyperphagia / physiopathology
  • Injections
  • Male
  • Neuropeptide Y / administration & dosage
  • Neuropeptide Y / metabolism*
  • Neuropeptide Y / pharmacology
  • Obesity / etiology*
  • Obesity / metabolism*
  • Obesity / physiopathology
  • Paraventricular Hypothalamic Nucleus / metabolism*
  • Rats
  • Rats, Wistar

Substances

  • Neuropeptide Y